STRONTIUM 3-HYDROXY-4-(2-(1-(SULFONATOMETHYL)-2-NAPHTHALENYL)DIAZENYL)-2-NAPHTHALENECARBOXYLATE
UNII QU3N7D2F8J
Substance Identification & Data
This profile provides standardized clinical and technical data for Strontium 3-hydroxy-4-(2-(1-(sulfonatomethyl)-2-naphthalenyl)diazenyl)-2-naphthalenecarboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QU3N7D2F8J.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 70703-34-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H14N2O6S.Sr JFGVPKUWJDAONQ-XMXXDQCKSA-L Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Strontium 3-hydroxy-4-(2-(1-(sulfonatomethyl)-2-naphthalenyl)diazenyl)-2-naphthalenecarboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.